New device aims to help NMOSD patients walk better

NCT ID NCT06374264

ENROLLING_BY_INVITATION Symptom relief Sponsor: MedRhythms, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 07, 2026 · Updated 3 times

Summary

This study tests a device called MR-C-014 that uses sound to help people with neuromyelitis optica spectrum disorder (NMOSD) who have trouble walking. Thirty adults will use the device for 30 minutes, three times a week for 8 weeks. The main goals are to see if people find it acceptable and safe, and to measure any changes in walking distance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MR-C-014 (a rhythmic auditory stimulation device)
What this could lead to: If it works, this could point toward a non-drug way to improve walking and endurance in people with NMOSD.
What could go wrong: This is a very small, early feasibility study with only 30 participants. It is not designed to prove the device works, only that it is safe and acceptable. Results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROMYELITIS OPTICA SPECTRUM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neuromyelitis optica

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEUROMYELITIS OPTICA SPECTRUM DISORDER

Contacts and locations

Locations

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States
Sheperd Center

Atlanta, Georgia, 30309, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.